Genocea Biosciences, Inc. (NASDAQ:GNCA) Stock - Is it Oversold?

Genocea Biosciences, Inc. (NASDAQ:GNCA) Stock - Is it Oversold?”

The mean target price as estimated by the analysts for the company has been recorded at $21.25.

The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. Some investors may only focus on the fundamentals of a company and completely ignore the technicals.

Traders will often use multiple moving averages to analyze a single security. Currently, Genocea Biosciences has an average volume of 499K. It has outperformed by 50.52% the S&P500.

Analysts expect Genocea Biosciences Inc (NASDAQ:GNCA) to report $-0.51 EPS on November, 2.They anticipate $0.06 EPS change or 13.33 % from last quarter's $-0.45 EPS. Genocea Biosciences, Inc. (GNCA) recently closed with rise of 4.23% to its 20-Day Simple Moving Average. Zacks Investment Research raised Genocea Biosciences from a "sell" rating to a "hold" rating in a report on Thursday, August 17th. Therefore 100% are positive. The rating was maintained by Needham on Tuesday, August 11 with "Buy". A sell rating on the other hand would be a recommendation to sell the security if now held, and avoid purchasing it on the open market. Genocea Biosciences has a average recommendation of "Buy" and an average price target of $10.23. The company presently has an average rating of "Buy" and an average target price of $14.52. The firm earned "Buy" rating on Tuesday, October 20 by Needham. As per Wednesday, August 9, the company rating was maintained by Cowen & Co. The firm has "Overweight" rating by PiperJaffray given on Thursday, September 29. Needham & Company LLC upgraded Genocea Biosciences from a hold rating to a buy rating and set a $12.00 price target for the company in a report on Monday, July 24th.

NASDAQ:GNCA) has reached an oversold level with an RSI (14) at 14.79.

Analysts recommendation for Genocea Biosciences, Inc.

More notable recent Genocea Biosciences Inc (NASDAQ:GNCA) news were published by: which released: "Genocea Biosciences (GNCA) Announces Positive Top-Line 12-Month Phase 2b Data ..." on July 24, 2017, also with their article: "BRIEF-Genocea announces strategic shift to immuno-oncology and the development ..." published on September 25, 2017, published: "Genocea shares almost halved on shift in drug development, layoffs" on September 25, 2017. Finally, Stifel Nicolaus cut shares of Genocea Biosciences from a "buy" rating to a "hold" rating and dropped their price target for the company from $15.00 to $2.50 in a research note on Monday.

Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. Dealing with market volatility is normal, but exploring all aspects of a company may be a good way to combat day to day volatility. The company uses its proprietary ATLAS™ antigen identification platform to build a pipeline of immunotherapies that now includes GEN-003, an immunotherapy for genital herpes, and GEN-009, its first neoantigen cancer vaccine, for which an Investigational New Drug application filing is expected by the end of 2017. It now has negative earnings.

Monday evening turned out to be a nightmare for Genocea Biosciences Inc (NASDAQ:GNCA) investors, after the drug maker announced that it has decided not to continue development of genital herpes treatment GEN-003, shifting to immuno-oncology and focusing on the development of neoantigen cancer vaccines.

Like this


27 September 2017
Leonardo DiCaprio Is Playing Theodore Roosevelt in a Martin Scorsese Biopic
They are also developing movies based on the true crime books The Devil in the White City and Killers of the Flower Moon . Scorsese and Emma Koskoff will produce through Sikelia, with Chuck Pacheco also producing.

27 September 2017
Investigation as bodies of husband and wife found in Rednal and Streetly
Mr Barnes posted a picture of the couple's wedding in May 2014 to his Facebook profile hours before the bodies were found. A man's body was found at a house in leafy Streetly, West Mids, in the early hours of yesterday morning.

27 September 2017
Carson Wentz says he'd give game check to Jake Elliott
The Eagles recently signed Elliott, 22, off the Bengals practice squad after Caleb Sturgis suffered a quad injury. But we're guessing that Elliott will be more interested in what Wentz said just before the kick was made.

27 September 2017
Statement Regarding Works in "Art and China after 1989"
The three artworks are a tiny fraction of the roughly 150 pieces that are part of the exhibit, which is set to open in October. The dogs are tethered to wooden treadmills so never touch, reports the New York Times .

27 September 2017
Navios Maritime Midstream Partn (NYSE:NAP) Trading Volume Significantly Lower
The leverage ratio can measure how much of a company's capital comes from debt. 5 funds opened positions while 1 raised stakes. News stories about Navios Maritime Holdings (NYSE:NM) have trended somewhat positive recently, according to Accern Sentiment.

27 September 2017
United States hails Saudi Arabia U-turn on women drivers
Last month, Saudi police arrested an Arab woman after video circulated showing her driving a auto in the Eastern Province. A committee will be formed to look into how to implement the new order, which is slated to come into effect in June 2018.

27 September 2017
Brokers Change Their Target Price On Boardwalk Pipeline Partners LP (NYSE:BWP)
The sales growth rate for a stock is a measure of how the stock's sales per share (SPS) has grown over a specific period of time. The investment managers in our partner's database now have: 225.25 million shares, down from 228.34 million shares in 2017Q1.

27 September 2017
Hannity tops Maddow in first head-to-head matchup
Sean Hannity threw the proverbial gauntlet with his 9 o'clock move on Fox News Channel Monday night. Maddow, meanwhile, drew 2.66 million viewers with 591,000 in the key demo.

27 September 2017
Twitter explains why Trump's North Korea tweet wasn't removed
Although Twitter is the significant mouthpiece of the President, it's caused the company more hassle than provided any benefit. But the company explained that the president's tweet was kept online because it is newsworthy and of "public interest".

27 September 2017
Kaufman Adaptive Moving Average Trending Higher for Deutsche X-trackers MSCI Europe Hedged Equity ETF (DBEU)
CCI is relatively high when prices are much higher than average, and relatively low when prices are much lower than the average. The simple moving average is a mathematical calculation that takes the average price (mean) for a given amount of time.